Alembic Pharmaceuticals Ltd.
NSE: APLLTD | BSE: 533573
₹734.90
₹-10.60
(-1.42%)
As on 09-Jun-2026 14:34IST
Market cap
₹14,447 Cr
Revenue (TTM)
₹7,345 Cr
P/E Ratio
21.4
P/B Ratio
2.5
Div. Yield
1.6 %
Quality Score
7/10
Growth Score
5/10
Valuation Score
5/10
Momentum Score
2/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹675 Cr
-
ROE
11.6 %
-
ROCE
13.5 %
-
Industry P/E
45.14
-
EV/EBITDA
13.3
-
Debt to Equity
0
-
Book Value
₹288.7
-
EPS
₹38.2
-
Face value
2
-
Shares outstanding
196,563,124
10 Years Aggregate
CFO
₹6,480.57 Cr
EBITDA
₹9,302.81 Cr
Net Profit
₹6,116.57 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Alembic Pharma
| -13.1 | -6.6 | 3.7 | -25.6 | 7.5 | -5.7 | 2.8 |
|
BSE Healthcare
| 8.6 | 1.3 | 8.3 | 9.1 | 24.9 | 13.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Alembic Pharma
| -19.3 | 39.2 | 32.6 | -28.6 | -23.1 | 87.7 | -2.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Alembic Pharma
|
734.9 | 14,447.4 | 7,344.9 | 670.6 | 10.9 | 13.7 | 21.4 | 2.5 |
| 3,183.0 | 26,473.9 | 1,339.4 | 356.4 | 33.2 | 23.2 | 74.3 | 16.0 | |
| 429.8 | 16,494.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92 | 4.2 | |
| 762.4 | 19,066.7 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32 | 3.7 | |
| 965.5 | 15,284.6 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38.4 | 2.2 | |
| 870.9 | 15,473.3 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 10.9 | 1.7 | |
| 1,724.5 | 19,648.0 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.4 | |
| 168.4 | 22,526.4 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 444.5 | 17,995.6 | 3,738.7 | 316.7 | 12.5 | 7.5 | 56.8 | 3.7 | |
| 1,880.6 | 30,808.5 | 3,373.0 | 199.0 | 12.6 | 5.9 | 144.6 | 6.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
5 min read•By Rajan Gulati
Mid caps that are thriving on growth & value
6 min read•By Rajan Gulati
We try to generate 20 per cent returns
2 min read•By Value Research
3 min read•By Mohammed Ekramul Haque
2 min read•By Mohammed Ekramul Haque
About Alembic Pharma
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology,... ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India. Read more
-
Incorporated
2010
-
Chairman
Chirayu Amin
-
Managing Director
Shaunak Amin
-
Group
Alembic
-
Headquarters
Vadodara, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Alembic Pharma
What is the current share price of Alembic Pharmaceuticals Ltd Today?
The share price of Alembic Pharmaceuticals Ltd is ₹734.90 (NSE) and ₹733.00 (BSE) as of 09-Jun-2026 14:34 IST. Alembic Pharmaceuticals Ltd has given a return of 7.54% in the last 3 years.
What is the current PB & PE ratio of Alembic Pharmaceuticals Ltd?
The P/E ratio of Alembic Pharmaceuticals Ltd is 21.41 times as on 09-Jun-2026, a 53 discount to its peers’ median range of 45.14 times.
The P/B ratio of Alembic Pharmaceuticals Ltd is 2.55 times as on 09-Jun-2026, a 35 discount to its peers’ median range of 3.90 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
31.31
|
3.52
|
|
2024
|
31.35
|
4.01
|
|
2023
|
28.50
|
2.23
|
|
2022
|
27.97
|
2.78
|
|
2021
|
16.55
|
3.74
|
What is the 52 Week High and Low of Alembic Pharmaceuticals Ltd?
The 52-week high and low of Alembic Pharmaceuticals Ltd are Rs 1,107.90 and Rs 635.80 as of 09-Jun-2026.
What is the market cap of Alembic Pharmaceuticals Ltd?
Alembic Pharmaceuticals Ltd has a market capitalisation of ₹ 14,447 Cr as on 09-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Alembic Pharmaceuticals Ltd?
Before investing in Alembic Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.